首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1629632

药物成瘾治疗市场：按类型、按治疗方法、按给药途径、按最终用户、按地区

Drug Addiction Treatment Market, By Types, By Treatment, By Route of Administration, By End User,By Geography

出版日期: 2024年11月26日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024年全球成瘾治疗市场规模为176.1亿美元，预计2031年将达287.2亿美元，2024年至2031年复合年增长率为7.2%。

报告范围		报告详情
基准年	2023年	2024年市场规模	176.1亿美元
实际资料	2019-2023	预测期	2024-2031
预测 2024-2031 年复合年增长率：	7.20%	2031年价值预测	287.2亿美元

图：2024 年按地区分類的成瘾治疗市场占有率（%）

近年来，随着药物滥用在已开发国家和新兴国家变得越来越普遍，全球药物成瘾治疗市场一直稳定发展。根据联合国毒品犯罪防制署(UNODC) 的数据，2020 年 6 月，全球约有 2.69 亿人至少吸过一次毒。非法药物的容易取得，加上社会经济的脆弱性，大大加剧了药物成瘾危机。作为回应，各国政府正加紧努力提供实证治疗服务，帮助人们克服吸毒障碍。这大大增加了全球成瘾治疗市场对各种药物和心理成瘾治疗和治疗方法的需求。

市场动态：

推动全球药物成瘾治疗市场成长的主要因素包括社会接受药物滥用障碍作为一种需要治疗而不是定罪的医疗状况、扩大治疗设施，其中包括政府增加医疗保健支出和增加阿片类止痛药的使用，这加剧了阿片类药物危机。然而，缺乏戒毒后社会支持计划、药物滥用治疗的耻辱以及缺乏接受过专门成瘾治疗培训的医疗保健专业人员等因素给市场相关人员带来了挑战。从积极的一面来看，正在进行的具有更好安全性和有效性的新型疗法的研究，以及数位技术在咨询项目中的整合，为相关人员提供了高成长机会。

本研究的主要特点

该报告对全球成瘾治疗市场进行了详细分析，并提出了以2023年为基准年的预测期（2024-2031）的市场规模和年复合成长率（CAGR%）。

它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。

根据公司亮点、产品系列、主要亮点、绩效和策略等参数，对全球成瘾治疗市场的主要企业进行概况分析。

本研究涵盖的主要企业包括 Indivior PLC、辉瑞公司、强生公司、Alkermes、Mallinckrodt Pharmaceuticals、Teva Pharmaceutical Industries、GSK Plc.、AbbVie Inc.、Otsuka Pharmaceutical Co., Ltd.、Lundbeck A/S、Hikma Pharmaceuticals、 Almesuticals、 Almesutical Plc.、Sandoz（诺华子公司）、AcelRx Pharmaceuticals、Nuvectra法人公司等

该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。

全球药物成瘾治疗市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

相关人员可以透过用于分析全球药物成瘾治疗市场的各种策略矩阵来促进他们的决策。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	US$ 17.61 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	7.20%	2031 Value Projection:	US$ 28.72 Bn

The global drug addiction treatment market has been witnessing steady growth in the recent past owing to the rising prevalence of drug abuse across both developed and developing nations worldwide. In June 2020, according to the United Nations Office on Drugs and Crime (UNODC), around 269 million people worldwide used drugs at least once in 2020. The easy availability of illicit substances coupled with socio-economic vulnerabilities has significantly contributed to the drug addiction crisis. In response, governments across countries have been ramping up efforts to provide evidence-based treatment services to help individuals overcome substance use disorders. This has majorly driven the demand for various pharmacological and psychological addiction treatment drugs and therapies in the global drug addiction treatment market.

Market Dynamics:

The key drivers propelling the global drug addiction treatment market growth include growing social acceptance of drug abuse disorders as a medical condition requiring treatment instead of criminalization, increasing healthcare spending by governments to expand treatment facilities, and rising number of opioid analgesic users contributing to the opioid crisis. However, factors such as lack of social support programs post-detoxification, stigma associated with substance abuse treatment, and scarcity of medical professionals with specialized addiction treatment training pose challenges to market players. On the positive side, ongoing research for novel treatment drugs with better safety and efficacy profiles as well as integration of digital technologies in counseling programs present high-growth opportunities for stakeholders.

Key Features of the Study:

This report provides an in-depth analysis of the global drug addiction treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global drug addiction treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Indivior PLC, Pfizer Inc., Johnson & Johnson, Alkermes, Mallinckrodt Pharmaceuticals, Teva Pharmaceutical Industries, GSK Plc., AbbVie Inc., Otsuka Pharmaceutical Co., Ltd., Lundbeck A/S, Hikma Pharmaceuticals, Alkermes Plc., Sandoz (a Novartis division), AcelRx Pharmaceuticals, and Nuvectra Corporation

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global drug addiction treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug addiction treatment market

Market Segmentation

By Types Insights (Revenue, USD Bn, 2019 - 2031)
- Opioid Addiction
- Benzodiazepine Addiction
- Barbiturate Addiction
- Others
By Treatment Insights (Revenue, USD Bn, 2019 - 2031)
- Therapy
- Medication
- Others
By Route of Administration Insights (Revenue, USD Bn, 2019 - 2031)
- Oral
- Parenteral
- Others
By End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals
- Specialty Clinics
- Rehabilitation Center
- Others
Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Indivior PLC
- Pfizer Inc.
- Johnson & Johnson
- Alkermes
- Mallinckrodt Pharmaceuticals
- Teva Pharmaceutical Industries
- GSK Plc.
- AbbVie Inc.
- Otsuka Pharmaceutical Co., Ltd.
- Lundbeck A/S
- Hikma Pharmaceuticals
- Alkermes Plc.
- Sandoz (a Novartis division)
- AcelRx Pharmaceuticals
- Nuvectra Corporation

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Drug Addiction Treatment Market, By Types
- Global Drug Addiction Treatment Market, By Treatment
- Global Drug Addiction Treatment Market, By Route of Administration
- Global Drug Addiction Treatment Market, By End User
- Global Drug Addiction Treatment Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Drug Addiction Treatment Market, By Types, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Opioid Addiction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Benzodiazepine Addiction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Barbiturate Addiction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Drug Addiction Treatment Market, By Treatment, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Medication
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Drug Addiction Treatment Market, By Route of Administration, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Drug Addiction Treatment Market, By End User, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Rehabilitation Center
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Drug Addiction Treatment Market, By Region, 2019 - 2031, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Types, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Types, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Types, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Types, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Types, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Types, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Indivior PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Alkermes
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mallinckrodt Pharmaceuticals
Teva Pharmaceutical Industries
GSK Plc.
AbbVie Inc.
Otsuka Pharmaceutical Co., Ltd.
Lundbeck A/S
Hikma Pharmaceuticals
Alkermes Plc.
Sandoz (a Novartis division)
AcelRx Pharmaceuticals
Nuvectra Corporation

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

药物成瘾治疗市场：按类型、按治疗方法、按给药途径、按最终用户、按地区